7+ hour, 4+ min ago  (338+ words) The U. S. Trade Representative is investigating Germany's drug pricing policies to determine if the country's actions leave the U. S. with a disproportionate share of global R&D costs. USTR ambassador Jamieson Greer has launched the probe under Section 301 of the Trade Act…...

8+ hour, 32+ min ago  (226+ words) Steve van Os, MD Seasoned biotech executive brings more than two decades of global clinical development, medical affairs and regulatory leadership across oncology, women's health and endocrinology In his role as Chief Medical Officer, Dr. van Os will lead Arletta's…...

9+ hour, 53+ min ago  (358+ words) Memento Medicines has bagged $93 million in series A proceeds, which the Boston biotech plans to funnel toward a newly licensed asset for retinal disorders. MMT-205 is designed to block the VEGF pathway and activate the Tie2 receptor simultaneously. Memento believes this…...

17+ hour ago  (147+ words) The details for the poster presentation, which will be presented by Tyrell Simkins, D. O. , Ph. D. , Senior Director, Clinical Development, are below: Poster Title: ALSTARS: A Precision Immunomodulatory Phase 2 Trial Of Coya 302 Targeting Regulatory T Cells And Neuroinflammation In ALS Authors: Tyrell…...

14+ hour, 12+ min ago  (159+ words) Portal is building the universal infrastructure for cell engineering across drug discovery and cell therapy. The proprietary platform leverages mechanoporation to enable efficient, scalable delivery of RNA, gene editors, probes, and other molecules into hard-to-transfect cells across many cell types…...

14+ hour, 18+ min ago  (252+ words) BOULDER, Colo. , June 18, 2026 /PRNewswire/ -- KROMATID, a leader in structural genomic integrity analysis for the cell and gene therapy industry, today announced the appointment of Matthew Hemstreet as Chief Executive Officer, succeeding Interim CEO Terry Opgenorth. Opgenorth was appointed Interim CEO…...

14+ hour, 19+ min ago  (77+ words) The agenda for Part I " Cardiometabolic is listed below: Vince Anzalone, CFA, Arrowhead Arrowhead's Technology and R&D Process James Hamilton, M. D. , MBA, Arrowhead Mixed Hyperlipidemia & ASCVD Treatment Landscape Steven Nissen, M. D. , Cleveland Clinic For more information, please visit arrowheadpharma. com, or…...

14+ hour, 21+ min ago  (183+ words) Award winners will be honoured at the Life Sciences BC Awards Gala on September 9, 2026, at the Vancouver Convention Centre West. The annual event brings together leaders from across the sector for an evening of recognition and connection. Early bird pricing…...

14+ hour, 21+ min ago  (154+ words) The offering consisted of 4, 000, 000 shares of its common stock, par value $0. 007 per share (or pre-funded warrants in lieu thereof) at a purchase price of $0. 80 per share (or $0. 793 per pre-funded warrant). Each pre-funded warrant will be exercisable for one share of…...

14+ hour, 48+ min ago  (570+ words) Bio Space Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics Collaboration combines Voro's tumor-activated biologics platform and T-cell engager (TCE) expertise with Alloy's antibody discovery and TCE engineering capabilities to develop novel…...